共有 50 笔近期内部人交易记录记录，涉及 Vivos Therapeutics, Inc. (VVOS), 包括 41 笔买入 和 6 笔卖出. 内部人买入总额为 $5.18M 内部人卖出总额为 $1.05M.
近期活跃的重要内部人包括 Skaff Michael C, Johnson Gregg C, Amman Bradford K.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — VVOS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-31 |
Skaff Michael C |
10 Percent Owner |
知情买入 |
429,957 |
$0.00 |
$43.00 |
429,957 |
| 2026-02-04 |
Johnson Gregg C |
Director |
未知 |
- |
- |
- |
3,997 |
| 2025-06-09 |
Skaff Michael C |
10 Percent Owner |
未知 |
725,258 |
$0.00 |
$72.53 |
- |
| 2024-11-26 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
149,533 |
$2.64 |
$394.77K |
180,533 |
| 2024-11-26 |
Huntsman Ronald Kirk |
Chief Executive Officer |
限制性股票授予 (RSU) |
315,421 |
$2.64 |
$832.71K |
364,755 |
| 2024-06-20 |
Sokolow Leonard J |
Director |
限制性股票授予 (RSU) |
4,000 |
$2.38 |
$9.52K |
7,467 |
| 2024-06-20 |
Krammer Anja B |
Director |
限制性股票授予 (RSU) |
4,000 |
$2.38 |
$9.52K |
7,067 |
| 2024-06-20 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
15,000 |
$2.38 |
$35.7K |
31,667 |
| 2024-06-20 |
Thompson Matthew |
Director |
限制性股票授予 (RSU) |
4,000 |
$2.38 |
$9.52K |
7,067 |
| 2024-06-20 |
Huntsman Ronald Kirk |
Chief Executive Officer |
限制性股票授予 (RSU) |
20,000 |
$2.38 |
$47.6K |
49,334 |
| 2024-06-20 |
Lindsay Mark F. |
Director |
限制性股票授予 (RSU) |
4,000 |
$2.38 |
$9.52K |
7,067 |
| 2024-06-20 |
Green Ralph Elias |
Director |
限制性股票授予 (RSU) |
4,000 |
$2.38 |
$9.52K |
7,067 |
| 2024-06-10 |
Skaff Michael C |
10 Percent Owner |
未知 |
3,220,266 |
$2.20 |
$7.1M |
- |
| 2023-06-20 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
14,000 |
$0.53 |
$7.42K |
86,521 |
| 2023-06-16 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
10,000 |
$0.54 |
$5.4K |
67,521 |
| 2023-06-15 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
21 |
$0.50 |
$10.50 |
57,521 |
| 2023-06-14 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
10,000 |
$0.49 |
$4.9K |
57,500 |
| 2022-12-23 |
Sokolow Leonard J |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.48 |
$14.4K |
76,667 |
| 2022-12-23 |
Krammer Anja B |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.48 |
$14.4K |
76,667 |
| 2022-12-23 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
200,000 |
$0.48 |
$96K |
500,001 |
| 2022-12-23 |
Thompson Matthew |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.48 |
$14.4K |
76,667 |
| 2022-12-23 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
20,000 |
$0.50 |
$10K |
47,500 |
| 2022-12-23 |
Lindsay Mark F. |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.48 |
$14.4K |
76,667 |
| 2022-12-23 |
Green Ralph Elias |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.48 |
$14.4K |
76,667 |
| 2022-05-31 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
8,000 |
$2.03 |
$16.24K |
23,500 |
| 2022-02-25 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
50,000 |
$3.27 |
$163.5K |
50,000 |
| 2022-02-25 |
Huntsman Ronald Kirk |
Chief Executive Officer |
限制性股票授予 (RSU) |
125,000 |
$3.27 |
$408.75K |
125,000 |
| 2021-09-21 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
5,000 |
$4.31 |
$21.55K |
15,500 |
| 2021-08-31 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
50,000 |
$5.26 |
$263K |
50,000 |
| 2021-08-17 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
5,000 |
$3.00 |
$15K |
10,500 |
| 2021-08-05 |
Sokolow Leonard J |
Director |
限制性股票授予 (RSU) |
30,000 |
$2.72 |
$81.6K |
46,667 |
| 2021-08-05 |
Krammer Anja B |
Director |
限制性股票授予 (RSU) |
30,000 |
$2.72 |
$81.6K |
46,667 |
| 2021-08-05 |
Thompson Matthew |
Director |
限制性股票授予 (RSU) |
30,000 |
$2.72 |
$81.6K |
46,667 |
| 2021-08-05 |
Singh Gurdev Dave |
10 Percent Owner, Officer: Chief Medical Officer |
限制性股票授予 (RSU) |
30,000 |
$2.72 |
$81.6K |
46,667 |
| 2021-08-05 |
Lindsay Mark F. |
Director |
限制性股票授予 (RSU) |
30,000 |
$2.72 |
$81.6K |
46,667 |
| 2021-08-05 |
Green Ralph Elias |
Director |
限制性股票授予 (RSU) |
30,000 |
$2.72 |
$81.6K |
46,667 |
| 2021-06-16 |
Huntsman Ronald Kirk |
Chief Executive Officer |
限制性股票授予 (RSU) |
125,000 |
$5.64 |
$705K |
125,000 |
| 2021-05-25 |
Amman Bradford K. |
Chief Financial Officer |
知情买入 |
1,000 |
$5.29 |
$5.29K |
2,000 |
| 2021-05-25 |
Huntsman Ronald Kirk |
Chief Executive Officer |
知情买入 |
4,000 |
$5.38 |
$21.52K |
5,500 |
| 2021-03-12 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
100,000 |
$7.50 |
$750K |
100,000 |
| 2021-03-12 |
Amman Bradford K. |
Chief Financial Officer |
限制性股票授予 (RSU) |
100,000 |
$7.50 |
$750K |
200,001 |
| 2020-12-24 |
Amman Bradford K. |
Chief Financial Officer |
知情买入 |
1,000 |
$7.38 |
$7.38K |
1,000 |
| 2020-12-23 |
Huntsman Ronald Kirk |
10 Percent Owner, Officer: Chief Executive Officer |
知情买入 |
1,000 |
$7.27 |
$7.27K |
1,500 |
| 2020-12-11 |
Huntsman Ronald Kirk |
10 Percent Owner, Officer: Chief Executive Officer |
知情买入 |
500 |
$8.50 |
$4.25K |
500 |
| 2020-12-10 |
Sokolow Leonard J |
Director |
处置 |
16,667 |
$7.50 |
$125K |
- |
| 2020-12-10 |
Krammer Anja B |
Director |
处置 |
16,667 |
$7.50 |
$125K |
- |
| 2020-12-10 |
Amman Bradford K. |
Chief Financial Officer |
处置 |
16,667 |
$7.50 |
$125K |
- |
| 2020-12-10 |
Thompson Matthew |
Director |
处置 |
16,667 |
$7.50 |
$125K |
- |
| 2020-12-10 |
Huntsman Ronald Kirk |
10 Percent Owner, Officer: Chairman & CEO |
处置 |
333,334 |
$1.65 |
$550K |
- |
| 2020-12-10 |
Singh Gurdev Dave |
10 Percent Owner, Officer: Chief Medical Officer |
处置 |
- |
- |
- |
700,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
